Skinvisible SKVI
OTC SKVI
$0.20 -0.23 (-53.49%)
At close: Sep 4, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Interest Expenses (2010 - 2026)

Skinvisible's (SKVI) quarterly Interest Expenses came in at $142716.0 in Q2 2026, little changed year-over-year from $142720.0 in Q2 2025, and up 1.04% quarter-over-quarter from $141246.0 in Q1 2026.

Analysis

Skinvisible (SKVI) Interest Expenses (2010 - 2026) Analysis & Trends

Skinvisible has disclosed Interest Expenses across 17 years of filings, most recently posting $142716.0 for Q2 2026.

  • In Q2 2026, Interest Expenses changed 0.0% year-over-year to $142716.0; the TTM figure through Jun 2026 stood at $572338.0 (down 7.73% YoY), while the FY2025 annual figure was $572249.0, down 14.52% from the prior year.
  • Interest Expenses came in at $142716.0 for Q2 2026 at Skinvisible, up from $141246.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.4 million in Q1 2023 to a low of $141153.0 in Q1 2025.
  • Average Interest Expenses over 5 years is $254757.4, with a median of $167387.5 recorded in 2023.
  • Year-over-year, Interest Expenses jumped 379.04% in 2023 and plunged 87.95% in 2024.
  • Over 5 years, Interest Expenses stood at $291177.0 in 2022, then tumbled by 42.56% to $167253.0 in 2023, then climbed by 0.84% to $168663.0 in 2024, then slipped by 14.51% to $144188.0 in 2025, then slipped by 1.02% to $142716.0 in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $142716.0 in Q2 2026, $141246.0 in Q1 2026, and $144188.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 281.00 Mn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -462.00 Mn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 23.78 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 582,000.00
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 2.90 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 142,716.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142,716.00
Mar 31, 2026 141,246.00
Dec 31, 2025 144,188.00
Sep 30, 2025 144,188.00
Jun 30, 2025 142,720.00
Mar 31, 2025 141,153.00
Dec 31, 2024 168,663.00
Sep 30, 2024 167,757.00
Jun 30, 2024 166,610.00
Mar 31, 2024 167,188.00
Dec 31, 2023 167,253.00
Sep 30, 2023 174,408.00
Jun 30, 2023 167,522.00
Mar 31, 2023 1.39 Mn
Dec 31, 2022 291,177.00
Sep 30, 2022 291,178.00
Jun 30, 2022 290,945.00
Mar 31, 2022 289,569.00
Dec 31, 2021 609,200.00
Sep 30, 2021 294,216.00